Resources
The following resources are available to help you treat Cold Agglutinin Disease (CAD) with ENJAYMO
Clinical Information
CADENZA Pivotal Trial Reprint
Read the published results from the CADENZA phase 3 placebo-controlled study
CARDINAL Pivotal Trial Reprint
Read the published results from the CARDINAL phase 3 study
ENJAYMO Infusion Guide
Guidance for you and your patients on the infusion of ENJAYMO
Access and Support
ENJAYMO Patient Solutions Enrollment Form
Enroll patients in ENJAYMO Patient Solutions for access to education services, reimbursement, and financial assistance programs
ENJAYMO Letter of Medical Necessity
A sample Letter of Medical Necessity to help support you and your patients for a prior authorization request or letter of appeal
ENJAYMO Appeal Checklist
If your patient's authorization for ENJAYMO is denied, you may be able to appeal the decision
ENJAYMO Billing and Coding Guide for Reimbursement
Information regarding coverage and other reimbursement considerations for ENJAYMO